» Articles » PMID: 33330918

Systematic Evaluation of the Effects of Genetic Variants on PIWI-interacting RNA Expression Across 33 Cancer Types

Overview
Specialty Biochemistry
Date 2020 Dec 17
PMID 33330918
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

PIWI-interacting RNAs (piRNAs) are an emerging class of non-coding RNAs involved in tumorigenesis. Expression quantitative trait locus (eQTL) analysis has been demonstrated to help reveal the genetic mechanism of single nucleotide polymorphisms (SNPs) in cancer etiology. However, there are no databases that have been constructed to provide an eQTL analysis between SNPs and piRNA expression. In this study, we collected genotyping and piRNA expression data for 10 997 samples across 33 cancer types from The Cancer Genome Atlas (TCGA). Using linear regression cis-eQTL analysis with adjustment of appropriate covariates, we identified millions of SNP-piRNA pairs in tumor (76 924 831) and normal (24 431 061) tissues. Further, we performed differential expression and survival analyses, and linked the eQTLs to genome-wide association study (GWAS) data to comprehensively decipher the functional roles of identified cis-piRNA eQTLs. Finally, we developed a user-friendly database, piRNA-eQTL (http://njmu-edu.cn:3838/piRNA-eQTL/), to help users query, browse and download corresponding eQTL results. In summary, piRNA-eQTL could serve as an important resource to assist the research community in understanding the roles of genetic variants and piRNAs in the development of cancers.

Citing Articles

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


Development and validation of a novel artificial intelligence algorithm for precise prediction the postoperative prognosis of esophageal squamous cell carcinoma.

Wang Z, Xiao Z, Zhang T, Lu M, Li H, Cao J BMC Cancer. 2025; 25(1):134.

PMID: 39849452 PMC: 11756118. DOI: 10.1186/s12885-025-13520-6.


Targeting piRNA-137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma.

Zhan Y, Tian F, Fan W, Li X, Wang X, Zhang H Adv Sci (Weinh). 2024; 12(6):e2414100.

PMID: 39692168 PMC: 11809383. DOI: 10.1002/advs.202414100.


piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision.

Shaker F, Sanad E, Elghazaly H, Hsia S, Hamdy N Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):47-68.

PMID: 39102033 PMC: 11787197. DOI: 10.1007/s00210-024-03308-z.


PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review.

Ahmadi Asouri S, Aghadavood E, Mirzaei H, Abaspour A, Shahaboddin M Heliyon. 2024; 10(13):e33767.

PMID: 39040379 PMC: 11261894. DOI: 10.1016/j.heliyon.2024.e33767.


References
1.
Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

2.
Ongen H, Andersen C, Bramsen J, Oster B, Rasmussen M, Ferreira P . Putative cis-regulatory drivers in colorectal cancer. Nature. 2014; 512(7512):87-90. DOI: 10.1038/nature13602. View

3.
Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai R . PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma. Theranostics. 2018; 8(19):5213-5230. PMC: 6276099. DOI: 10.7150/thno.28001. View

4.
Calabrese C, Davidson N, Demircioglu D, Fonseca N, He Y, Kahles A . Genomic basis for RNA alterations in cancer. Nature. 2020; 578(7793):129-136. PMC: 7054216. DOI: 10.1038/s41586-020-1970-0. View

5.
Gilad Y, Rifkin S, Pritchard J . Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 2008; 24(8):408-15. PMC: 2583071. DOI: 10.1016/j.tig.2008.06.001. View